279 related articles for article (PubMed ID: 20508203)
21. Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling.
Zhou MS; Chadipiralla K; Mendez AJ; Jaimes EA; Silverstein RL; Webster K; Raij L
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H563-74. PubMed ID: 23748423
[TBL] [Abstract][Full Text] [Related]
22. Enhancing PPARγ by HDAC inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice.
Gao Q; Wei A; Chen F; Chen X; Ding W; Ding Z; Wu Z; Du R; Cao W
Pharmacol Res; 2020 Oct; 160():105059. PubMed ID: 32621955
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y
J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406
[TBL] [Abstract][Full Text] [Related]
24. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
Boss M; Kemmerer M; Brüne B; Namgaladze D
Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
[TBL] [Abstract][Full Text] [Related]
25. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
[TBL] [Abstract][Full Text] [Related]
26. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression.
Chen H; Yang J; Zhang Q; Chen LH; Wang Q
Circ J; 2012; 76(4):995-1003. PubMed ID: 22293444
[TBL] [Abstract][Full Text] [Related]
27. Effect of beta-3 adrenoceptor stimulation on the levels of ApoA-I, PPARα, and PPARγ in apolipoprotein E-deficient mice.
Shi ST; Li YF; Guo YQ; Wang ZH
J Cardiovasc Pharmacol; 2014 Nov; 64(5):407-11. PubMed ID: 24979391
[TBL] [Abstract][Full Text] [Related]
28. GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice.
Ditiatkovski M; Toh BH; Bobik A
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2337-44. PubMed ID: 16873730
[TBL] [Abstract][Full Text] [Related]
29. Peptidoglycan induced expression of peroxisome proliferator-activated receptor γ in mouse peritoneal macrophages: role of ERK and JNK MAP kinases.
Bhatt KH; Sodhi A; Chakraborty R
Cytokine; 2012 Dec; 60(3):778-86. PubMed ID: 22925536
[TBL] [Abstract][Full Text] [Related]
30. Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice.
Dong P; Pan L; Zhang X; Zhang W; Wang X; Jiang M; Chen Y; Duan Y; Wu H; Xu Y; Zhang P; Zhu Y
J Ethnopharmacol; 2017 Feb; 198():479-488. PubMed ID: 28119096
[TBL] [Abstract][Full Text] [Related]
31. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
[TBL] [Abstract][Full Text] [Related]
32. Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway.
He XW; Yu D; Li WL; Zheng Z; Lv CL; Li C; Liu P; Xu CQ; Hu XF; Jin XP
Biomed Pharmacother; 2016 Oct; 83():257-264. PubMed ID: 27389392
[TBL] [Abstract][Full Text] [Related]
33. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
[TBL] [Abstract][Full Text] [Related]
34. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
35. Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2009 Jul; 385(2):269-72. PubMed ID: 19460355
[TBL] [Abstract][Full Text] [Related]
36. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis.
Ma L; Zhong J; Zhao Z; Luo Z; Ma S; Sun J; He H; Zhu T; Liu D; Zhu Z; Tepel M
Cardiovasc Res; 2011 Dec; 92(3):504-13. PubMed ID: 21908651
[TBL] [Abstract][Full Text] [Related]
37. Microarray analysis of gene expression in mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibility.
Yuan Z; Miyoshi T; Bao Y; Sheehan JP; Matsumoto AH; Shi W
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1336-43. PubMed ID: 19304945
[TBL] [Abstract][Full Text] [Related]
38. Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis.
Lim S; Lee KS; Lee JE; Park HS; Kim KM; Moon JH; Choi SH; Park KS; Kim YB; Jang HC
Atherosclerosis; 2015 Nov; 243(1):107-19. PubMed ID: 26363808
[TBL] [Abstract][Full Text] [Related]
39. Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells.
Ma X; Li SF; Qin ZS; Ye J; Zhao ZL; Fang HH; Yao ZW; Gu MN; Hu YW
Cardiovasc Pathol; 2015; 24(4):230-5. PubMed ID: 25600616
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor-gamma1 gene therapy attenuates atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice.
Hu Q; Zhang XJ; Zhang C; Zhao YX; He H; Liu CX; Feng JB; Jiang H; Yang FL; Zhang CX; Zhang Y
Hum Gene Ther; 2008 Mar; 19(3):287-299. PubMed ID: 18302511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
